Ernexa Therapeutics (ERNA) R&D In Process (2021 - 2023)
Historic R&D In Process for Ernexa Therapeutics (ERNA) over the last 3 years, with Q2 2023 value amounting to $460000.0.
- Ernexa Therapeutics' R&D In Process changed N/A to $460000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was -$80.1 million, marking a year-over-year change of. This contributed to the annual value of $460000.0 for FY2023, which is N/A changed from last year.
- Latest data reveals that Ernexa Therapeutics reported R&D In Process of $460000.0 as of Q2 2023.
- Over the past 5 years, Ernexa Therapeutics' R&D In Process peaked at $80.5 million during Q3 2021, and registered a low of -$80.5 million during Q4 2022.
- Its 3-year average for R&D In Process is $153333.3, with a median of $460000.0 in 2023.